Good afternoon, everybody. I’m Chris Schott at JPMorgan, and it’s my pleasure to be introducing AbbVie today. From the company, we have a presentation from Rick Gonzalez, AbbVie’s Chairman and CEO….
S&P Capital IQ 2023
All news about ABBVIE INC.
Analyst Recommendations on ABBVIE INC.
Sales 2022
58 284 M – –
Net income 2022
14 494 M – –
Net Debt 2022
54 799 M – –
P/E ratio 2022
17,6x
Yield 2022
3,89%
Capitalization
257 B 257 B –
EV / Sales 2022
5,36x
EV / Sales 2023
5,58x
Nbr of Employees
50 000
Free-Float
97,4%
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Day
Week
Technical analysis trends ABBVIE INC.
Short Term
Mid-Term
Long Term
Trends
Bearish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser’s settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
145,65 $
Average target price
162,12 $
Spread / Average Target
11,3%
Please enable JavaScript in your browser’s settings to use dynamic charts.
Source link
